About Novartis AG 
Novartis AG
Pharmaceuticals & Biotechnology
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Company Coordinates 
Company Details
Lichtstrasse 35 , BASEL None : 4056
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 15 Foreign Institutions (0.08%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Joerg Reinhardt
Independent Non-Executive Chairman of the Board
Dr. Enrico Vanni
Independent Non-Executive Vice Chairman of the Board
Ms. Bridgette Heller
Director
Dr. Simon Moroney
Director
Dr. Nancy Andrews
Non-Executive Independent Director
Revenue and Profits:
Net Sales:
11,608 Million
(Quarterly Results - Jun 2025)
Net Profit:
3,324 Million
Pharmaceuticals & Biotechnology
CHF 224,339 Million ()
17.00
NA
0.00%
0.29
36.86%
6.36






